C12Y 301/2601
Ribonuclease ix
Official title: Ribonuclease IX (3.1.26.10)
C12Y301/2601 (Ribonuclease ix) appears on 6 US grants and 6 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 6
- Assignees
- 2
- Inventors
- 7
- Latest grant
- 28 Feb 2017
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 2 |
| 2011 | 1 | 0 |
| 2012 | 1 | 2 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 2 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
By publication year.
Recent patents
- Therapeutic ribonucleases28 Feb 2017US 9,579,365 B2Quintessence Biosciences, Inc.
- Cosmetic use of a protein belonging to the ribonuclease family3 Nov 2015US 9,176,144 B2L'oreal
- Therapeutic ribonucleases14 Apr 2015US 9,006,407 B2Quintessence Biosciences, Inc.
- Therapeutic ribonucleases14 Jan 2014US 8,628,768 B2Quintessence Biosciences, Inc.
- Therapeutic ribonucleases10 Jul 2012US 8,216,567 B2Quintessence Biosciences, Inc.
- Therapeutic ribonucleases30 Jul 2015US 2015/0209415 A1Quintessence Biosciences, Inc.
- Therapeutic ribonucleases8 May 2014US 2014/0128457 A1Quintessence Biosciences, Inc.
- Therapeutic ribonucleases1 Nov 2012US 2012/0276077 A1Quintessence Biosciences, Inc.
- Therapeutic ribonucleases5 Jan 2012US 2012/0003150 A1Quintessence Biosciences, Inc.
- Cosmetic use of a protein belonging to the ribonuclease family9 Dec 2010US 2010/0311666 A1L'oreal
Most cited
By later US patents
- Therapeutic ribonucleases25US 8,029,782 B2Quintessence Biosciences, Inc. · 2011
- Therapeutic ribonucleases7US 8,216,567 B2Quintessence Biosciences, Inc. · 2012
- Therapeutic ribonucleases1US 8,628,768 B2Quintessence Biosciences, Inc. · 2014
- Cosmetic use of a protein belonging to the ribonuclease family1US 9,176,144 B2L'oreal · 2015